IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,228,671 | +15.0% | 613,673 | +23.7% | 0.00% | 0.0% |
| Q2 2023 | $23,677,370 | +35.7% | 495,965 | +11.9% | 0.00% | 0.0% |
| Q1 2023 | $17,444,249 | +44.7% | 443,310 | +4.0% | 0.00% | – |
| Q4 2022 | $12,053,577 | -0.6% | 426,072 | +5.6% | 0.00% | – |
| Q3 2022 | $12,125,000 | -14.0% | 403,412 | -2.9% | 0.00% | – |
| Q2 2022 | $14,096,000 | -23.7% | 415,291 | +0.8% | 0.00% | – |
| Q1 2022 | $18,469,000 | -4.9% | 411,879 | -2.0% | 0.00% | – |
| Q4 2021 | $19,411,000 | +38.6% | 420,094 | +0.8% | 0.00% | – |
| Q3 2021 | $14,002,000 | +17.5% | 416,845 | +2.9% | 0.00% | – |
| Q2 2021 | $11,912,000 | +12.8% | 405,012 | -1.1% | 0.00% | – |
| Q1 2021 | $10,559,000 | +13.9% | 409,710 | +0.8% | 0.00% | – |
| Q4 2020 | $9,271,000 | +4.2% | 406,599 | -2.3% | 0.00% | – |
| Q3 2020 | $8,900,000 | -9.6% | 416,283 | -1.9% | 0.00% | – |
| Q2 2020 | $9,849,000 | +28.2% | 424,322 | +18.0% | 0.00% | – |
| Q1 2020 | $7,680,000 | -9.8% | 359,718 | -1.2% | 0.00% | – |
| Q4 2019 | $8,512,000 | +3.3% | 364,045 | -7.1% | 0.00% | – |
| Q3 2019 | $8,239,000 | +3.1% | 391,963 | +0.4% | 0.00% | – |
| Q2 2019 | $7,988,000 | -16.7% | 390,592 | +14.4% | 0.00% | – |
| Q1 2019 | $9,595,000 | +22.0% | 341,550 | +6.2% | 0.00% | – |
| Q4 2018 | $7,867,000 | -35.9% | 321,620 | -2.7% | 0.00% | -100.0% |
| Q3 2018 | $12,276,000 | +158.0% | 330,441 | +44.1% | 0.00% | – |
| Q2 2018 | $4,759,000 | +660.2% | 229,353 | +427.3% | 0.00% | – |
| Q1 2018 | $626,000 | -4.4% | 43,493 | +0.6% | 0.00% | – |
| Q4 2017 | $655,000 | +60.1% | 43,224 | +1.6% | 0.00% | – |
| Q3 2017 | $409,000 | +11.4% | 42,540 | -0.5% | 0.00% | – |
| Q2 2017 | $367,000 | -80.7% | 42,749 | -80.0% | 0.00% | – |
| Q1 2017 | $1,903,000 | +95050.0% | 213,689 | +111779.1% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 191 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -94.2% | 191 | -92.1% | 0.00% | – |
| Q2 2016 | $52,000 | +477.8% | 2,407 | +429.0% | 0.00% | – |
| Q1 2016 | $9,000 | +50.0% | 455 | +127.5% | 0.00% | – |
| Q4 2015 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |